A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
about
Quantitative phenotypic and pathway profiling guides rational drug combination strategiesThree-dimensional cell culture systems and their applications in drug discovery and cell-based biosensorsEnergy-requiring uptake of prostasomes and PC3 cell-derived exosomes into non-malignant and malignant cells.Heat-shock factor 2 is a suppressor of prostate cancer invasion.N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of α-cateninPhenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironmentSegmentation of Image Data from Complex Organotypic 3D Models of Cancer Tissues with Markov Random Fields.Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesChemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cellsRecapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibitionA 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug developmentPCaAnalyser: a 2D-image analysis based module for effective determination of prostate cancer progression in 3D cultureRapid patterning of 1-D collagenous topography as an ECM protein fibril platform for image cytometryQuantification of dynamic morphological drug responses in 3D organotypic cell cultures by automated image analysisDevelopment of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineeringOptimization of Invasion-Specific Effects of Betulin Derivatives on Prostate Cancer Cells through Lead Development.Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated ProteinsAdvances in multicellular spheroids formationAdvances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.Three-dimensional chemotaxis-driven aggregation of tumor cells.A Novel Computer-Assisted Approach to evaluate Multicellular Tumor Spheroid Invasion Assay.Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics.Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide.CCR4 is a determinant of melanoma brain metastasisIn vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.Microfluidic 3D models of cancer.Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer.Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells.Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning.MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels.Time-lapse imaging assay using the BioStation CT: a sensitive drug-screening method for three-dimensional cell cultureThree-dimensional (3D) tumor spheroid invasion assay.Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment.Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids
P2860
Q27021150-BF020C61-27B2-4796-AA44-32FF3F1B6A0EQ27023623-28BF6267-94F3-4427-80D5-9E4632B47BD3Q27303191-5B532099-1F56-46A8-867D-085AAC08AFADQ27309985-BD775027-4F09-488C-9414-307191788CC0Q27317689-C1930843-AEF7-470A-84EA-235FC14B0AD9Q27335274-A31B7968-08F9-4319-95AB-C35BA22B376AQ27338443-E42BE4BC-9355-4B15-9E04-0C6F4F2E379BQ28066286-D0BCC6CB-DB11-403A-A167-BFF1AFA3768AQ28484299-CF77F3BF-4DEB-4321-B7B6-441324612B9FQ28484418-CA359589-E76D-4ED1-A939-692A6A3B70C0Q28534459-889002F2-D6B5-4A38-B568-7D8B00698645Q28535321-71D6498F-E850-4B2A-9643-4ABB1AD75BCCQ28537778-A06A472C-A0B8-4197-B9B3-CD28ADC5E387Q28538607-ED625DA6-4124-4F1C-8AC0-7E432A1DEDB4Q28541338-EE82D24B-7D52-478D-B3FF-8641A37B3555Q28547191-00AB7B90-951A-4350-823A-56B3453CF012Q28552225-9DA4EB49-EA4B-4979-84F9-746E1DA39009Q30361108-6A05C78D-A880-499A-A3C4-C483FEAF7859Q30514021-1A8787D6-4F7C-4A12-BFB4-CEC9DE744082Q30585006-4F7C986C-7E51-4CD4-86E8-3350300B0B55Q30668765-99D8677D-5A7A-46D7-9000-F6629EF50356Q30820970-044F0BCE-9340-49E3-BE19-021338AD20F9Q31115121-AD68831D-C3A7-49C5-A815-EF42DEA8E46CQ33605227-A22FE4CA-A56E-45C6-933C-C6ACEF86D216Q33650423-FB0F93A8-F50A-4114-B1E7-42944669E753Q33761639-E53899B2-57D9-494E-8C5E-A47CF77CCE58Q34368788-4BD92365-9984-4C0B-B077-E5E210AC8455Q34646530-08A50A79-A9B3-4E72-AD12-D909209D853FQ34784755-B2DC67C4-EE7E-46B9-91E3-9A34B7688A45Q35000828-A8923B56-3465-4AEA-9CFD-D905B66485F0Q35129375-1C8F6C61-2B5D-4ABB-AF72-F15BECD138FAQ35137514-ADA8851F-060A-4765-A71F-691991B32BF0Q35744004-89A819BC-317A-40F0-94F7-5A31A1E72EB4Q35754291-976AA9A1-025A-4D00-A3BE-A341290DF4B2Q35972563-FCB65079-AE83-4334-958E-5A3B7C3DA22CQ35985227-C3F49E8F-C522-4138-9B3D-E768E086D5B0Q36022437-D4BA7A1D-23CB-44ED-8ED8-4491EF5F99B8Q36047094-87B8FD41-3A76-4CAC-8420-8858BC6947D2Q36160786-2575B858-E19D-4652-A748-63B04D209F1BQ36303680-A7063052-0E01-410F-B365-F746B92DF57D
P2860
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A comprehensive panel of three ...... h, invasion and drug responses
@ast
A comprehensive panel of three ...... h, invasion and drug responses
@en
A comprehensive panel of three ...... h, invasion and drug responses
@nl
type
label
A comprehensive panel of three ...... h, invasion and drug responses
@ast
A comprehensive panel of three ...... h, invasion and drug responses
@en
A comprehensive panel of three ...... h, invasion and drug responses
@nl
prefLabel
A comprehensive panel of three ...... h, invasion and drug responses
@ast
A comprehensive panel of three ...... h, invasion and drug responses
@en
A comprehensive panel of three ...... h, invasion and drug responses
@nl
P2093
P2860
P50
P3181
P1433
P1476
A comprehensive panel of three ...... h, invasion and drug responses
@en
P2093
Antti Happonen
Johannes Virtanen
John-Patrick Mpindi
Matias Knuuttila
Rami Mäkelä
Ville Härmä
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0010431
P407
P577
2010-01-01T00:00:00Z